US Bancorp’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-31
Closed -$1K 3580
2016
Q1
$1K Hold
31
﹤0.01% 3450
2015
Q4
$1K Hold
31
﹤0.01% 3520
2015
Q3
$1K Sell
31
-10
-24% -$451 ﹤0.01% 3514
2015
Q2
$2K Hold
41
﹤0.01% 3427
2015
Q1
$3K Buy
41
+10
+32% +$773 ﹤0.01% 3386
2014
Q4
$2K Hold
31
﹤0.01% 3416
2014
Q3
$2K Sell
31
-253
-89% -$17.2K ﹤0.01% 3381
2014
Q2
$20K Hold
284
﹤0.01% 2858
2014
Q1
$25K Hold
284
﹤0.01% 2750
2013
Q4
$22K Hold
284
﹤0.01% 2736
2013
Q3
$25K Hold
284
﹤0.01% 2591
2013
Q2
$24K Buy
+284
New +$23.5K ﹤0.01% 2582

Other funds holding HHS

US Bancorp's HHS Position: Q2 2016 in Review

US Bancorp sold out of Harte-Hanks (HHS) in Q2 2016, closing a stake of 31 shares — an estimated $1K sold.

US Bancorp first reported a position in HHS in Q2 2013 and held it in 12 quarters. The position peaked at $25K in Q1 2014. 107 funds tracked by Wall St. Rank hold HHS as of Q2 2016.

  • US Bancorp reported no remaining Harte-Hanks position as of Q2 2016 after selling out during the quarter.
  • US Bancorp sold 31 Harte-Hanks shares in Q2 2016, an estimated $1K.
  • US Bancorp first reported a position in Harte-Hanks in Q2 2013 and held it in 12 quarters.
  • US Bancorp's Harte-Hanks position peaked at $25K in Q1 2014.
  • 107 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2016.

Based on US Bancorp's 13F filing for Q2 2016, filed 10 Aug 2016.